These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 31552714)

  • 1. Complementary Participation of Genetics and Epigenetics in Development of NSAID-exacerbated Respiratory Disease.
    Lee JU; Park JS; Chang HS; Park CS
    Allergy Asthma Immunol Res; 2019 Nov; 11(6):779-794. PubMed ID: 31552714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variants in arachidonic acid pathway genes associated with NSAID-exacerbated respiratory disease.
    Ayuso P; Plaza-Serón Mdel C; Blanca-López N; Doña I; Campo P; Canto G; Laguna JJ; Bartra J; Soriano-Gomis V; Blanca M; Cornejo-García JA; Perkins JR
    Pharmacogenomics; 2015 Jul; 16(8):825-39. PubMed ID: 26067486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NSAID-Exacerbated Respiratory Disease (NERD): From Pathogenesis to Improved Care.
    Woo SD; Luu QQ; Park HS
    Front Pharmacol; 2020; 11():1147. PubMed ID: 32848759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging Biomarkers Beyond Leukotrienes for the Management of Nonsteroidal Anti-inflammatory Drug (NSAID)-Exacerbated Respiratory Disease.
    Rhyou HI; Nam YH; Park HS
    Allergy Asthma Immunol Res; 2022 Mar; 14(2):153-167. PubMed ID: 35255534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in Human
    Reigada-Rivera ML; Lozano CS; Rodilla EM; García-Sánchez A; García-Solaesa V; Toledano FL; González ID; Isidoro-García M
    Genes (Basel); 2022 Mar; 13(4):. PubMed ID: 35456412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-Adherent Leukocytes Associated With Cutaneous Cross-Reactive Hypersensitivity to Nonsteroidal Anti-Inflammatory Drugs.
    Jurado-Escobar R; Doña I; Bogas-Herrera G; Pérez-Sánchez N; Salas M; Laguna JJ; Muñoz-Cano R; Mayorga C; Torres MJ; Cornejo-García JA
    Front Pharmacol; 2020; 11():594427. PubMed ID: 33658935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin E
    Mastalerz L; Tyrak KE; Ignacak M; Konduracka E; Mejza F; Ćmiel A; Buczek M; Kot A; Oleś K; Sanak M
    Allergy; 2019 May; 74(5):922-932. PubMed ID: 30446997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonsteroidal anti-inflammatory drug hypersensitivity in the Asia-Pacific.
    Thong BY
    Asia Pac Allergy; 2018 Oct; 8(4):e38. PubMed ID: 30402405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonsteroidal anti-inflammatory drugs-exacerbated respiratory disease in adolescents.
    Ertoy Karagol HI; Yilmaz O; Topal E; Ceylan A; Bakirtas A
    Int Forum Allergy Rhinol; 2015 May; 5(5):392-8. PubMed ID: 25755210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonsteroidal anti-inflammatory drug (NSAID) exacerbated respiratory disease phenotype: Topical NSAID and asthma control - A possible oversight link.
    Tan JHY; Hsu AAL
    Respir Med; 2016 Sep; 118():1-3. PubMed ID: 27578463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide DNA methylation profile of peripheral blood lymphocytes from subjects with nonsteroidal anti-inflammatory drug-induced respiratory diseases.
    Lee JU; Soo Chang H; Kyung Kim M; Park SL; Kim JH; Park JS; Park CS
    Pharmacogenet Genomics; 2022 Aug; 32(6):226-234. PubMed ID: 35696287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between TMEM196 polymorphisms and NSAID-exacerbated respiratory disease in asthma.
    Lee JU; Chang HS; Baek DG; Shin HD; Park CS; Park JS
    Pharmacogenet Genomics; 2019 Jun; 29(4):69-75. PubMed ID: 30694883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors of NSAID-exacerbated respiratory disease: A population-based study.
    Helevä A; Murtomäki A; Huhtala H; Bousquet J; Luukkainen A; Karjalainen J; Lemmetyinen R; Haukka J; Torkki P; Nuutinen M; Toppila-Salmi S
    Clin Transl Allergy; 2023 Aug; 13(8):e12296. PubMed ID: 37632242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-Reported Control of Asthma, Nasal Polyposis, and Middle-Ear Symptoms in NSAID-Exacerbated Respiratory Disease.
    Suikkila A; Hafrén L; Lyly A; Klockars T; Saarinen R
    Front Allergy; 2021; 2():716169. PubMed ID: 35386973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unraveling the genetic basis of aspirin hypersensitivity in asthma beyond arachidonate pathways.
    Park SM; Park JS; Park HS; Park CS
    Allergy Asthma Immunol Res; 2013 Sep; 5(5):258-76. PubMed ID: 24003382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of phenotypic clusters of nonsteroidal anti-inflammatory drugs exacerbated respiratory disease.
    Lee HY; Ye YM; Kim SH; Ban GY; Kim SC; Kim JH; Shin YS; Park HS
    Allergy; 2017 Apr; 72(4):616-626. PubMed ID: 27805264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential Biomarkers for NSAID-Exacerbated Respiratory Disease.
    Park H; Choi Y; Jung CG; Park HS
    Mediators Inflamm; 2017; 2017():8160148. PubMed ID: 28852271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of L-plastin in nasal polyp of patients with nonsteroidal anti-inflammatory drug-exacerbated respiratory disease.
    Takabayashi T; Tanaka Y; Susuki D; Yoshida K; Tomita K; Sakashita M; Imoto Y; Kato Y; Narita N; Nakayama T; Haruna S; Schleimer RP; Fujieda S
    Allergy; 2019 Jul; 74(7):1307-1316. PubMed ID: 30479022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonsteroidal anti-inflammatory drug administration in children with history of wheeze.
    Sih K; Goldman RD
    Can Fam Physician; 2016 Aug; 62(8):633-4. PubMed ID: 27521389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NSAIDs-hypersensitivity often induces a blended reaction pattern involving multiple organs.
    Doña I; Barrionuevo E; Salas M; Laguna JJ; Agúndez J; García-Martín E; Bogas G; Perkins JR; Cornejo-García JA; Torres MJ
    Sci Rep; 2018 Nov; 8(1):16710. PubMed ID: 30420763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.